HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nagalingeswaran Kumarasamy Selected Research

Selenium

1/2019Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nagalingeswaran Kumarasamy Research Topics

Disease

23Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 03/2005
21Infections
01/2021 - 11/2006
15Tuberculosis (Tuberculoses)
01/2023 - 02/2005
10HIV Infections (HIV Infection)
01/2023 - 01/2012
8Coinfection
10/2022 - 04/2009
7Anemia
01/2017 - 05/2007
7Disease Progression
09/2016 - 09/2006
6Inflammation (Inflammations)
01/2022 - 01/2016
5Liver Diseases (Liver Disease)
11/2022 - 08/2008
3Hepatitis B
10/2022 - 01/2016
3Malnutrition (Nutritional Deficiencies)
01/2019 - 10/2007
3Drug-Related Side Effects and Adverse Reactions
01/2019 - 10/2007
3Hepatitis C
01/2016 - 01/2014
3Immune Reconstitution Inflammatory Syndrome
11/2013 - 11/2007
2Fibrosis (Cirrhosis)
11/2022 - 06/2015
2Weight Gain
01/2022 - 09/2015
2Viremia
09/2021 - 04/2012
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020 - 01/2020
2Lipodystrophy
01/2019 - 09/2017
2Hypertension (High Blood Pressure)
01/2019 - 01/2018
2Malaria
01/2019 - 09/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 06/2015
2Body Weight (Weight, Body)
07/2016 - 10/2007
2Overweight
07/2016 - 09/2015
2Opportunistic Infections (Opportunistic Infection)
01/2015 - 07/2014
1Uveitis
04/2023
1Hyperglycemia
01/2023
1Hypertriglyceridemia
01/2023
1Hypercholesterolemia
01/2023
1Dyslipidemias (Dyslipidemia)
01/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Neoplasms (Cancer)
01/2021
1COVID-19
11/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2020
1Neurocognitive Disorders (Clerambault Syndrome)
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Bacterial Infections (Bacterial Infection)
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Cognitive Dysfunction
01/2019
1Vitamin A Deficiency
01/2019
1Diabetes Mellitus
01/2019
1Gastroenteritis
11/2018

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
04/2023 - 06/2015
7RNA (Ribonucleic Acid)IBA
01/2022 - 04/2009
6LopinavirFDA Link
01/2019 - 09/2014
6Tenofovir (Viread)FDA Link
01/2018 - 01/2014
5Ritonavir (Norvir)FDA Link
09/2016 - 09/2014
4Reverse Transcriptase InhibitorsIBA
01/2022 - 10/2007
4Interferon-gamma (Interferon, gamma)IBA
01/2020 - 01/2015
4C-Reactive ProteinIBA
01/2019 - 01/2015
4Zidovudine (Retrovir)FDA LinkGeneric
09/2017 - 10/2013
3Alanine Transaminase (SGPT)IBA
11/2022 - 08/2008
3Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2022 - 04/2009
3VaccinesIBA
01/2021 - 11/2018
3Rifampin (Rifampicin)FDA LinkGeneric
01/2020 - 01/2019
3Stavudine (Zerit)FDA LinkGeneric
01/2019 - 01/2014
3Protease Inhibitors (Protease Inhibitor)IBA
01/2019 - 01/2012
3Immunoglobulin M (IgM)IBA
01/2019 - 05/2007
3Lamivudine (Epivir)FDA Link
01/2018 - 09/2015
3efavirenz (Sustiva)FDA Link
09/2017 - 03/2005
3Hemoglobins (Hemoglobin)IBA
06/2016 - 12/2010
3NucleosidesIBA
01/2015 - 10/2007
2Lipopolysaccharide ReceptorsIBA
01/2019 - 07/2016
2DNA (Deoxyribonucleic Acid)IBA
12/2017 - 04/2009
2Emtricitabine (Emtriva)FDA Link
09/2017 - 09/2015
2RacivirIBA
09/2017 - 09/2015
2Isoniazid (Ftivazide)FDA LinkGeneric
03/2016 - 01/2012
2Raltegravir PotassiumFDA Link
01/2015 - 01/2015
2LipopolysaccharidesIBA
01/2015 - 11/2007
2AntigensIBA
11/2013 - 10/2008
2AntibodiesIBA
09/2012 - 08/2008
2Immunoglobulin G (IgG)IBA
04/2009 - 08/2008
2EnzymesIBA
10/2008 - 11/2006
1oxidized low density lipoproteinIBA
01/2023
1Integrase InhibitorsIBA
01/2023
1Indicators and Reagents (Reagents)IBA
11/2022
1Surface Antigens (Surface Antigen)IBA
10/2022
1HLA-DR Antigens (HLA-DR)IBA
01/2022
1IntegrasesIBA
01/2022
1Combined VaccinesIBA
01/2021
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2020
1Tuberculin (PPD)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1ChemokinesIBA
01/2019
1HDL CholesterolIBA
01/2019
1abacavir (Ziagen)FDA Link
01/2019
1SeleniumIBA
01/2019
1MicronutrientsIBA
01/2019
1Vitamin A (Retinol)FDA LinkGeneric
01/2019
1CholesterolIBA
01/2019
1Carotenoids (Carotene)IBA
01/2019
1MacrolidesIBA
01/2019
1IronIBA
01/2019
1CD40 Ligand (CD40L)IBA
11/2018

Therapy/Procedure

36Therapeutics
01/2021 - 03/2005
16Art Therapy
01/2023 - 01/2013
16Highly Active Antiretroviral Therapy (HAART)
12/2019 - 02/2005
1Polypharmacy
01/2019